Position in MIRA
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$340,352
-$44,207 QoQ
Shares Held
359,401
0.0% QoQ
Ownership
0.855%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#2
of 26 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MIRA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cross Staff Investments Inc holds $6,352,495 across 7 Drug Manufacturers - General names. MIRA ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,300 | $2,758,689 | |
| 2 | JNJ |
Johnson & Johnson
|
5,477 | $1,390,993 | |
| 3 | MRK |
Merck & Co., Inc.
|
7,397 | $950,514 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
6,350 | $365,887 | |
| 5 | MIRA |
Mira Pharmaceuticals, Inc.
This page
|
359,401 | $340,352 | |
| 6 | PFE |
Pfizer Inc
|
13,263 | $319,373 | |
| 7 | AMGN |
Amgen Inc
|
626 | $226,687 |
All Filings in MIRA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $340,352 | 359,401 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $384,559 | 359,401 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $542,695 | 359,401 | Shares | Sole | 2026-02-27 | |
| 2025-09-30 | $488,785 | 359,401 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $434,875 | 359,401 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $356,132 | 363,401 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $417,127 | 365,901 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $475,671 | 365,901 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $244,226 | 383,401 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $421,741 | 383,401 | Shares | Sole | 2024-05-01 | |
| No filing history on record for this holder in this stock. | ||||||